Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Envista Holdings (MEX:NVST) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
Envista Holdings Forward PE Ratio Related Terms
Envista Holdings Forward PE Ratio Historical Data
* Premium members only.
The historical data trend for Envista Holdings's Forward PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Envista Holdings Forward PE Ratio Chart
Envista Holdings Annual Data
Trend
2025-12
Forward PE Ratio
16.25
Envista Holdings Quarterly Data
2025-06
2025-09
2025-12
2026-03
Forward PE Ratio
18.76
15.77
16.25
14.66
MEX:NVST vs MMSI, MMED, STVN: Forward PE Ratio Comparison
For the Medical Instruments & Supplies subindustry, Envista Holdings's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Envista Holdings Forward PE Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Envista Holdings's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where Envista Holdings's Forward PE Ratio falls into.
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
Envista Holdings (MEX:NVST) has a Forward PE Ratio of 14.76 as of Jul. 26, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Envista Holdings and its competitors. According to the industry distribution chart, Envista Holdings ranks #189 out of 391 companies in the Medical Devices & Instruments industry, placing it in the top 48.3%.
Is Envista Holdings' Forward PE Ratio too high?
Envista Holdings' current Forward PE Ratio is 14.76. The Medical Devices & Instruments industry median Forward PE Ratio is 18.69. Envista Holdings' value of 14.76 is 21% below this industry median. Based on the distribution chart, Envista Holdings ranks #189 out of 391 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Envista Holdings has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Envista Holdings' Forward PE Ratio compare to MMSI and MMED?
According to the Medical Devices & Instruments industry distribution chart, Envista Holdings ranks #189 out of 391 companies for Forward PE Ratio. This puts Envista Holdings in the upper half of its industry. The industry median Forward PE Ratio is 18.69. Envista Holdings' value of 14.76 is 21% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Medical Devices & Instruments company?
The median Forward PE Ratio among Medical Devices & Instruments companies is 18.69, based on 391 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Envista Holdings's current Forward PE Ratio of 14.76 is 21% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Envista Holdings and its competitors. For the Medical Devices & Instruments industry, the median Forward PE Ratio is 18.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Envista Holdings's current Forward PE Ratio is 14.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Envista Holdings stock overvalued right now?
Envista Holdings (MEX:NVST) has a current Forward PE Ratio of 14.76. The stock's GF Value™ is MXN336.13, compared to a current price of MXN370.00 — trading 10.1% above its estimated fair value. The current Forward PE Ratio is 14.76 and 21% below the Medical Devices & Instruments industry median of 18.69. Envista Holdings' overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Envista Holdings (MEX:NVST), the current Forward PE Ratio is 14.76 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Envista Holdings (MEX:NVST) Overvalued in 2026?
Based on GuruFocus' analysis, Envista Holdings stock appears to be overvalued.
The current stock price of MXN370.00 is trading 10.1% above its estimated GF Value™ of MXN336.13.
Key valuation signals for MEX:NVST:
Forward PE Ratio: 14.76
GF Value™: MXN336.13 vs. price of MXN370.00 (10.1% above fair value)
Industry Position: 21% below the Medical Devices & Instruments median (#189 of 391)
No single metric tells the full story. See the MEX:NVST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.
80GF Score
Get the complete analysis for MEX:NVST
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:NVST has been successfully added to your 
